We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
iLap icon

1.35 by iridium interactive Ltd


Oct 18, 2015

About iLap

English

iLap app for the Causes, Diagnosis, Treatment and Prevention of liver diseases.

The Institute of Liver & Biliary Sciences (ILBS) has been established by the Government of the National Capital Territory of Delhi as an autonomous institute, under the Societies act.

The mission of ILBS is to become a dedicated international centre of excellence for the diagnosis, management and advanced training and research in the field of liver and biliary diseases.

The first phase of ILBS is already functional having 180 hospital beds, 74 of which cater as intensive care (ICU) beds.

The second phase of ILBS, likely to be operational by early 2012, will add a dedicated multi-storie research complex, auditorium, guest-house, hepato-biliary oncology unit, additional beds and residential accommodation.

The ILBS aims to provide a healthy work environment to its faculty and staff.

ILBS is a deemed university under the UGC act and it aspires to become a unique model for an academic career both for the national and international students and the faculty.

What's New in the Latest Version 1.35

Last updated on Oct 18, 2015

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request iLap Update 1.35

Uploaded by

Aylen Torres

Requires Android

Android 2.2+

Show More

iLap Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.